Connection
Stephen Waldo to Time Factors
This is a "connection" page, showing publications Stephen Waldo has written about Time Factors.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
1.565 |
|
|
|
-
Bricker RS, Glorioso TJ, Jawaid O, Plomondon ME, Valle JA, Armstrong EJ, Waldo SW. Temporal Trends and Site Variation in High-Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. J Am Heart Assoc. 2019 12 17; 8(24):e014906.
Score: 0.083
-
Valle JA, Glorioso TJ, Schuetze KB, Grunwald GK, Armstrong EJ, Waldo SW. Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention. Circ Cardiovasc Interv. 2019 05; 12(5):e007636.
Score: 0.079
-
Bricker RS, Valle JA, Plomondon ME, Armstrong EJ, Waldo SW. Causes of Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005355.
Score: 0.079
-
Bagai J, Hess E, Penny WF, Plomondon ME, Waldo SW. Outcomes of Transradial PCI compared to Transfemoral PCI in veterans with anemia: Insight from the VA Clinical Assessment, Reporting and Tracking (CART) program. Cardiovasc Revasc Med. 2019 Nov; 20(11):990-996.
Score: 0.078
-
Prouse AF, Langner P, Plomondon ME, Ho PM, Valle JA, Bar?n AE, Armstrong EJ, Waldo SW. Temporal trends in the management and clinical outcomes of lower extremity arterial thromboembolism within a national Veteran population. Vasc Med. 2019 02; 24(1):41-49.
Score: 0.075
-
Waldo SW, Gokhale M, O'Donnell CI, Plomondon ME, Valle JA, Armstrong EJ, Schofield R, Fihn SD, Maddox TM. Temporal Trends in Coronary?Angiography and Percutaneous?Coronary?Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2018 05 14; 11(9):879-888.
Score: 0.074
-
Valle JA, Kaltenbach LA, Bradley SM, Yeh RW, Rao SV, Gurm HS, Armstrong EJ, Messenger JC, Waldo SW. Variation in the Adoption of Transradial?Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry. JACC Cardiovasc Interv. 2017 11 27; 10(22):2242-2254.
Score: 0.071
-
Armstrong EJ, Stanislawski MA, Kokkinidis DG, Plomondon ME, Bar?n AE, Giri J, Shunk KA, Banerjee S, Maddox TM, Waldo SW. Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program. Catheter Cardiovasc Interv. 2018 05 01; 91(6):1009-1017.
Score: 0.070
-
Waldo SW, O'Donnell CI, Prouse A, Plomondon ME, Rao SV, Maddox TM, Ho PM, Armstrong EJ. Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program. Catheter Cardiovasc Interv. 2018 02 15; 91(3):425-433.
Score: 0.070
-
Waldo SW, Abtahian F, Kennedy KF, Scirica BM, Mahmood S, Yeh RW. Incidence and predictors of incomplete revascularization in a contemporary cohort. Coron Artery Dis. 2016 May; 27(3):191-8.
Score: 0.064
-
Waldo SW, Brenner DA, Li S, Alexander K, Ganz P. Reperfusion times and in-hospital outcomes among patients with an isolated posterior myocardial infarction: insights from the National Cardiovascular Data Registry (NCDR). Am Heart J. 2014 Mar; 167(3):350-4.
Score: 0.055
-
Waldo SW, Armstrong EJ, Kulkarni A, Hoffmayer KS, Hsue P, Ganz P, McCabe JM. Clinical characteristics and reperfusion times among patients with an isolated posterior myocardial infarction. J Invasive Cardiol. 2013 Aug; 25(8):371-5.
Score: 0.053
-
Brenner DA, Dela Cruz M, Thomas K, McCabe JM, Ganz P, Hsue PY, Waldo SW. Emergency medical service utilization and door-to-balloon time for HIV-infected individuals with ST-elevation myocardial infarction. Int J Cardiol. 2013 Oct 12; 168(5):4808-9.
Score: 0.053
-
Waldo SW, Armstrong EJ, Yeo KK, Patel M, Reeves R, Macgregor JS, Low RI, Mahmud E, Rogers JH, Shunk K. Procedural success and long-term outcomes of aspiration thrombectomy for the treatment of stent thrombosis. Catheter Cardiovasc Interv. 2013 Dec 01; 82(7):1048-53.
Score: 0.053
-
Waldo SW, Armstrong EJ, Yeo KK, Mahmud E, Patel M, Reeves R, MacGregor JS, Low RI, Rogers JH, Shunk KA. Comparison of procedural success and long-term outcomes of stent thrombosis in coronary bypass grafts versus native coronary arteries. Am J Cardiol. 2013 Mar 01; 111(5):689-94.
Score: 0.051
-
Waldo SW, Rosario HS, Penn AH, Schmid-Sch?nbein GW. Pancreatic digestive enzymes are potent generators of mediators for leukocyte activation and mortality. Shock. 2003 Aug; 20(2):138-43.
Score: 0.027
-
Kokkinidis DG, Jawaid O, Cantu D, Martinsen BJ, Igyarto Z, Valle JA, Waldo SW, Armstrong EJ. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions. J Endovasc Ther. 2020 Jun; 27(3):492-501.
Score: 0.021
-
Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes. Catheter Cardiovasc Interv. 2020 02 15; 95(3):439-446.
Score: 0.021
-
Cantu D, Jawaid O, Kokkinidis D, Giannopoulos S, Valle JA, Waldo SW, Singh GD, Armstrong EJ. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease. Cardiovasc Revasc Med. 2020 07; 21(7):867-874.
Score: 0.021
-
Xie JX, Gunzburger EC, Kaun L, Plomondon ME, Bar?n AE, Waldo SW, Virani SS, Maddox TM, Mavromatis K. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005455.
Score: 0.021
-
Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ. Turbo-Power? Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis. Cardiovasc Revasc Med. 2020 06; 21(6):771-778.
Score: 0.020
-
Rymer JA, O'Donnell CI, Plomondon ME, Hess PL, Donahue M, Hebert PL, Shroff A, Swaminathan RV, Waldo SW, Seto AH, Helfrich CD, Rao SV. Same-day discharge among patients undergoing elective PCI: Insights from the VA CART Program. Am Heart J. 2019 12; 218:75-83.
Score: 0.020
-
Hall PS, O'Donnell CI, Mathew V, Garcia S, Bavry AA, Banerjee S, Jneid H, Denktas AE, Giacomini JC, Grossman PM, Aggarwal K, Zimmet JM, Tseng EE, Gozdecki L, Burke L, Bertog SC, Buchbinder M, Plomondon ME, Waldo SW, Shunk KA. Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2019 11 11; 12(21):2186-2194.
Score: 0.020
-
Kokkinidis DG, Foley TR, Cotter R, Hossain P, Alvandi B, Jawaid O, Haider MN, Singh GD, Waldo SW, Laird JR, Armstrong EJ. Acute and Midterm Outcomes of Antegrade vs Retrograde Crossing Strategies for Endovascular Treatment of Iliac Artery Chronic Total Occlusions. J Endovasc Ther. 2019 06; 26(3):342-349.
Score: 0.020
-
Nathan AS, Shah RM, Khatana SA, Dayoub E, Chatterjee P, Desai ND, Waldo SW, Yeh RW, Groeneveld PW, Giri J. Effect of Public Reporting on the Utilization of Coronary Angiography After Out-of-Hospital Cardiac Arrest. Circ Cardiovasc Interv. 2019 04; 12(4):e007564.
Score: 0.020
-
Hu PT, Jones WS, Glorioso TJ, Bar?n AE, Grunwald GK, Waldo SW, Maddox TM, Vidovich M, Banerjee S, Rao SV. Predictors and Outcomes of Staged?Versus One-Time Multivessel?Revascularization in Multivessel?Coronary?Artery Disease: Insights From the VA CART Program. JACC Cardiovasc Interv. 2018 11 26; 11(22):2265-2273.
Score: 0.019
-
Cotter R, Kokkinidis DG, Choy HH, Singh GD, Rogers RK, Waldo SW, Laird JR, Armstrong EJ. Long-term outcomes of carotid artery stenting in patients with a contralateral carotid artery occlusion. Catheter Cardiovasc Interv. 2019 01 01; 93(1):E49-E55.
Score: 0.019
-
Valle JA, Glorioso TJ, Maddox TM, Armstrong EJ, Waldo SW, Bradley SM, Ho PM. Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes. Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004623.
Score: 0.019
-
Smolderen KG, Plomondon ME, Armstrong EJ, Hess E, Waldo S, Tsai TT, Maddox TM. Depression and long-term prognostic outcomes following peripheral endovascular interventions in the VA Healthcare System. Vasc Med. 2018 10; 23(5):454-460.
Score: 0.019
-
Kokkinidis DG, Alvandi B, Hossain P, Foley TR, Kielhorn CE, Singh GD, Waldo SW, Laird JR, Armstrong EJ. Midterm Outcomes After Endovascular Intervention for Occluded vs Stenosed External Iliac Arteries. J Endovasc Ther. 2018 Apr; 25(2):183-191.
Score: 0.018
-
Kokkinidis DG, Alvandi B, Cotter R, Hossain P, Foley TR, Singh GD, Waldo SW, Laird JR, Armstrong EJ. Long-term outcomes after re-entry device use for recanalization of common iliac artery chronic total occlusions. Catheter Cardiovasc Interv. 2018 09 01; 92(3):526-532.
Score: 0.018
-
Kokkinidis DG, Hossain P, Jawaid O, Alvandi B, Foley TR, Singh GD, Waldo SW, Laird JR, Armstrong EJ. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis. J Endovasc Ther. 2018 Feb; 25(1):81-88.
Score: 0.018
-
Kokkinidis DG, Prouse AF, Avner SJ, Lee JM, Waldo SW, Armstrong EJ. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2018 08 01; 92(2):285-299.
Score: 0.018
-
Choy HK, Kokkinidis DG, Cotter R, Singh GD, Rogers RK, Waldo SW, Laird JR, Armstrong EJ. Long-term outcomes after carotid artery stenting of patients with prior neck irradiation or surgery. Cardiovasc Revasc Med. 2018 Apr - May; 19(3 Pt B):327-332.
Score: 0.018
-
Foley TR, Singh GD, Kokkinidis DG, Choy HK, Pham T, Amsterdam EA, Rutledge JC, Waldo SW, Armstrong EJ, Laird JR. High-Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease. J Am Heart Assoc. 2017 07 15; 6(7).
Score: 0.017
-
Khaira KB, Brinza E, Singh GD, Amsterdam EA, Waldo SW, Tong K, Pandya K, Laird JR, Armstrong EJ. Long-term outcomes in patients with critical limb ischemia and heart failure with preserved or reduced ejection fraction. Vasc Med. 2017 08; 22(4):307-315.
Score: 0.017
-
Strom JB, McCabe JM, Waldo SW, Pinto DS, Kennedy KF, Feldman DN, Yeh RW. Management of Patients With Cardiac Arrest Complicating Myocardial Infarction in New York Before and After Public Reporting Policy Changes. Circ Cardiovasc Interv. 2017 May; 10(5).
Score: 0.017
-
Singh GD, Brinza EK, Hildebrand J, Waldo SW, Foley TR, Laird JR, Armstrong EJ. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries. J Endovasc Ther. 2017 06; 24(3):321-330.
Score: 0.017
-
Singh GD, Armstrong EJ, Waldo SW, Alvandi B, Brinza E, Hildebrand J, Amsterdam EA, Humphries MD, Laird JR. Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia. Vasc Med. 2017 06; 22(3):210-217.
Score: 0.017
-
Foley TR, Cotter RP, Kokkinidis DG, Nguyen DD, Waldo SW, Armstrong EJ. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease. Catheter Cardiovasc Interv. 2017 May; 89(6):1078-1085.
Score: 0.017
-
Armstrong EJ, Graham LA, Waldo SW, Valle JA, Maddox TM, Hawn MT. Incomplete Revascularization Is Associated With an Increased Risk for?Major Adverse Cardiovascular Events?Among Patients Undergoing Noncardiac Surgery. JACC Cardiovasc Interv. 2017 02 27; 10(4):329-338.
Score: 0.017
-
Armstrong EJ, Graham L, Waldo SW, Valle JA, Maddox TM, Hawn MT. Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Catheter Cardiovasc Interv. 2017 Mar 01; 89(4):617-627.
Score: 0.016
-
Yeo KK, Armstrong EJ, Soni K, Waldo SW, Patel M, Reeves R, MacGregor JS, Low RI, Shunk KA, Mahmud E, Rogers JH. Long-term outcomes of angiographically confirmed coronary stent thrombosis: results from a multicentre California registry. EuroIntervention. 2015 Jun; 11(2):188-95.
Score: 0.015
-
Armstrong EJ, Sab S, Singh GD, Lim W, Yeo KK, Waldo SW, Patel M, Reeves R, MacGregor JS, Low RI, Shunk KA, Mahmud E, Rogers JH. Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry. JACC Cardiovasc Interv. 2014 Oct; 7(10):1105-13.
Score: 0.014
-
Wasfy JH, Strom JB, Waldo SW, O'Brien C, Wimmer NJ, Zai AH, Luttrell J, Spertus JA, Kennedy KF, Normand SL, Mauri L, Yeh RW. Clinical preventability of 30-day readmission after percutaneous coronary intervention. J Am Heart Assoc. 2014 Sep 26; 3(5):e001290.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|